# Study of HX15001 in Adult Healthy Volunteers.

> **NCT06999720** · PHASE1 · RECRUITING · sponsor: **Helixon Biotechnology (Suzhou) Co., Ltd** · enrollment: 62 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** HX15001 (SAD)
- **DRUG:** Placebo
- **DRUG:** HX15001 (MAD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06999720
- **Lead sponsor:** Helixon Biotechnology (Suzhou) Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-11
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06999720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06999720, "Study of HX15001 in Adult Healthy Volunteers.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06999720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*